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The growing world population 
and increasing living standards on 
one hand result in higher natural 
resource consumption and on the 
other hand demand higher quality of 
products with significant ecological 
and economic impacts. More food, 
better health, active aging, cleaner 
water and better air are some of 
the major demands of the growing 
societies. A transformation in the 
industry is needed to meet these 
demands with low or no waste pro-
duction, reduced release of green-
house gases, using energy efficient 
and still cost effective and competi-
tive manufacturing processes.  Sig-
nificant break-through progress is 
required to support this transition 
in the bio-industry sector. These in-
clude the optimization of strains and 
bioreactions based on new carbon 
source feedstreams, screening and 
engineering enzymes with optimal 
activity for instance in very viscous 
solutions or even solid matrices, the 
design of new bioreactors ensuring 
optimum distribution of nutrients 
and oxygen with minimal or no gen-
eration of gradients, increased pro-
duction scales (where appropriate) 
and/or titers, intensified processes 
and novel separation technologies 
and processes suitable for process-
ing both the large volume/low value 
and low volume/high value products.
In the biopharmaceutical in-
dustry, the maturation of technolo-
gies and tools such as genomics, 
proteomics, systems biology, and 
molecular modelling, and also the 
emergence of novel technologies, in-
cluding bio-chips, stem cell technol-
ogy, cell gene therapies, microfluid-
ics and high throughput screening 
also demand significant develop-
ments in biochemical engineering. 
The integration of this knowledge in 
cross-disciplinary biochemical engi-
neering activities and its transla-
tion into bioprocesses brings, for in-
stance, new opportunities to design 
better therapies based on genes, 
stem-cells, monoclonal antibodies 
and nanobodies. To support this fast 
growing sector of biopharmaceutical 
industries, significant technological 
advancement is also needed.
Biochemical engineering is pivotal 
to further develop and support the full 
transition to a bio-economy era. The 
new European Society of Biochemical 
Engineering Science (ESBES) has a 
relevant role in promoting the platform 
for excellent scientific discussion and 
bringing academia and industry to-
gether to translate innovation into ac-
tion. ESBES brings together national 
chemical and biochemical engineer-
ing societies from across Europe, aca-
demia and industry to help translate 
knowledge into processes and prod-
ucts and to advance the education 
of future generations of biochemical 
engineers. ESBES organizes top level 
conferences and workshops to shape 
and design the future of process tech-
nology and industrial biotechnology 
to develop future economic activities, 
based on efficient, clean and sustain-
able manufacturing.
The European Symposium on 
Biochemical Engineering Sciences 
2016 took place in Dublin in Sep-
tember 2016. This symposium rep-
resented an important landmark of 
the new ESBES society and brought 
together 268 paying participants of 
which 128 were students and 25% of 
the participants came from industry 
and small and medium-sized enter-
prises (SMEs). 
This Special issue of the Biotech-
nology Journal, the official journal of 
the society, showcases some of the 
technical programe of the sympo-
sium and the advances and topics of 
interest in biochemical engineering, 
ranging from bioeconomy [1], sus-
tainability and solvent free extrac-
tions [2], discovery and optimization 
of new biocatalysts [3], design of 
new biotherapeuticals [4], as well 
as new process control and design 
approaches based on modeling and 
predictive tools [5].
A range of review articles over-
view the state of the art in a broad ar-
eas from methodologies for exploring 
and controlling microbial populations 
[6] and biofilms [7]; manufacturing 
various important products, such as 
lipoproteins [8] and microbial biosur-
factants [9], but also iron oxide nano-
particle-nanofibre composites [10] to 
challenges and opportunities in the 
application of cascading enzymatic 
microreactors [11] and microscale 
methods for cell disruption [12]. A se-
lection of research articles then report 
on the latest research developments 
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in a range of areas that are going to 
be of interest to a wide readership 
base of the Biotechnology Journal. 
We hope you find these useful and 
hope to welcome you at the next 
ESBES Symposium in Lisbon in 2018.
www.esbes.org
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